BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 18442197)

  • 1. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells.
    Imaoka A; Shima T; Kato K; Mizuno S; Uehara T; Matsumoto S; Setoyama H; Hara T; Umesaki Y
    World J Gastroenterol; 2008 Apr; 14(16):2511-6. PubMed ID: 18442197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells.
    Helwig U; Lammers KM; Rizzello F; Brigidi P; Rohleder V; Caramelli E; Gionchetti P; Schrezenmeir J; Foelsch UR; Schreiber S; Campieri M
    World J Gastroenterol; 2006 Oct; 12(37):5978-86. PubMed ID: 17009396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probiotic Yogurt Culture Bifidobacterium Animalis Subsp. Lactis BB-12 and Lactobacillus Acidophilus LA-5 Modulate the Cytokine Secretion by Peripheral Blood Mononuclear Cells from Patients with Ulcerative Colitis.
    Sheikhi A; Shakerian M; Giti H; Baghaeifar M; Jafarzadeh A; Ghaed V; Heibor MR; Baharifar N; Dadafarin Z; Bashirpour G
    Drug Res (Stuttg); 2016 Jun; 66(6):300-5. PubMed ID: 26909690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probiotic Lactobacillus and Bifidobacterium Strains Counteract Adherent-Invasive
    Leccese G; Bibi A; Mazza S; Facciotti F; Caprioli F; Landini P; Paroni M
    Cells; 2020 Aug; 9(8):. PubMed ID: 32752244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Combined Effect of Potential Probiotic Bacillus licheniformis MCC 2514 and Bifidobacterium breve NCIM 5671 Towards Anti-inflammatory Activity on HT-29 Cell Lines.
    H S R; Halami PM
    Probiotics Antimicrob Proteins; 2023 Apr; 15(2):351-362. PubMed ID: 34581975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of six probiotic strains on immune function in vitro.
    Dong H; Rowland I; Yaqoob P
    Br J Nutr; 2012 Aug; 108(3):459-70. PubMed ID: 22054064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport.
    Ménard S; Candalh C; Bambou JC; Terpend K; Cerf-Bensussan N; Heyman M
    Gut; 2004 Jun; 53(6):821-8. PubMed ID: 15138208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probiotic strains modulate cytokine production and the immune interplay between human peripheral blood mononucear cells and colon cancer cells.
    Djaldetti M; Bessler H
    FEMS Microbiol Lett; 2017 Feb; 364(3):. PubMed ID: 28104778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.
    Riedel CU; Foata F; Philippe D; Adolfsson O; Eikmanns BJ; Blum S
    World J Gastroenterol; 2006 Jun; 12(23):3729-35. PubMed ID: 16773690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines.
    Wang ZL; Wang YD; Wang K; Li JA; Li L
    Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactic acid bacteria and bifidobacteria attenuate the proinflammatory response in intestinal epithelial cells induced by Salmonella enterica serovar Typhimurium.
    Carey CM; Kostrzynska M
    Can J Microbiol; 2013 Jan; 59(1):9-17. PubMed ID: 23391223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis.
    Matsuoka K; Uemura Y; Kanai T; Kunisaki R; Suzuki Y; Yokoyama K; Yoshimura N; Hibi T
    Dig Dis Sci; 2018 Jul; 63(7):1910-1919. PubMed ID: 29450747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications.
    Medina M; Izquierdo E; Ennahar S; Sanz Y
    Clin Exp Immunol; 2007 Dec; 150(3):531-8. PubMed ID: 17956582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure of intestinal epithelial cells to UV-killed Lactobacillus GG but not Bifidobacterium breve enhances the effector immune response in vitro.
    van Hoffen E; Korthagen NM; de Kivit S; Schouten B; Bardoel B; Duivelshof A; Knol J; Garssen J; Willemsen LE
    Int Arch Allergy Immunol; 2010; 152(2):159-68. PubMed ID: 20016198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free culture supernatant of Bifidobacterium breve CNCM I-4035 decreases pro-inflammatory cytokines in human dendritic cells challenged with Salmonella typhi through TLR activation.
    Bermudez-Brito M; Muñoz-Quezada S; Gomez-Llorente C; Matencio E; Bernal MJ; Romero F; Gil A
    PLoS One; 2013; 8(3):e59370. PubMed ID: 23555025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactobacillus plantarum 299: beneficial in vitro immunomodulation in cells extracted from inflamed human colon.
    Pathmakanthan S; Li CK; Cowie J; Hawkey CJ
    J Gastroenterol Hepatol; 2004 Feb; 19(2):166-73. PubMed ID: 14731126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytokine formation by human intestinal bacteria in gut epithelial cell lines.
    Bahrami B; Macfarlane S; Macfarlane GT
    J Appl Microbiol; 2011 Jan; 110(1):353-63. PubMed ID: 21070518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis.
    Cui HH; Chen CL; Wang JD; Yang YJ; Cun Y; Wu JB; Liu YH; Dan HL; Jian YT; Chen XQ
    World J Gastroenterol; 2004 May; 10(10):1521-5. PubMed ID: 15133865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Bifidobacterium strains drive different immune responses in vitro.
    López P; Gueimonde M; Margolles A; Suárez A
    Int J Food Microbiol; 2010 Mar; 138(1-2):157-65. PubMed ID: 20071048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study.
    Ishikawa H; Matsumoto S; Ohashi Y; Imaoka A; Setoyama H; Umesaki Y; Tanaka R; Otani T
    Digestion; 2011; 84(2):128-33. PubMed ID: 21525768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.